Insilico Medicine vs Recursion

Side-by-side comparison of Insilico Medicine and Recursion: pricing, features, API access, and community ratings.

AI comparison summary

Generating comparison…

	Insilico Medicine Generative AI platform for end-to-end drug discovery, from target identification to clinical trials Visit	Recursion Pioneering AI-driven drug discovery to decode biology and radically improve lives Visit
Category	Healthcare & biotech	Healthcare & biotech
Pricing	Enterprise	Enterprise
Starting price
Free tier
Audience	Technical	Technical
API available
Open source
Self-hostable
Model provider	Insilico Medicine (proprietary LLLMs)	Proprietary (Recursion OS)
Founded	2014	2013
Headquarters	Cambridge, USA	Salt Lake City, USA
Key strengths	·End-to-end AI-driven drug discovery pipeline (target ID to clinical trials) ·Generative chemistry and biology AI (Chemistry42, Generative Biologics) ·Large Language of Life Models (LLLMs) for biomedical research ·Validated therapeutic pipeline with programs in Phase I/II trials	·Massive proprietary biological dataset (>50 petabytes) spanning phenomics, transcriptomics, proteomics, and more ·Automated wet lab with robotics and computer vision generating millions of cell experiments per week ·Recursion OS — a continuously improving AI drug discovery and development platform ·BioHive-2 supercomputer built with NVIDIA for biopharma-scale compute